COMMUNIQUÉS West-GlobeNewswire

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

10/01/2018 - 14:00

NORTHVALE, N.J., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ) today reported positive topline results from pivotal bioequivalence studies for an undisclosed [...]

PositiveID Announces 2017 Highlights and Projects Continued 30% Growth

10/01/2018 - 14:00

DELRAY BEACH, Fla., Jan. 10, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today 2017 highlights for its [...]

Delcath Announces Special Protocol Agreement Modification With FDA

10/01/2018 - 14:00

NEW YORK, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has concluded a [...]

Vericel to Present at the 20th Annual Needham Growth Conference

10/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, [...]

Atara Biotherapeutics Announces FDA Clearance to Proceed with Enrollment at U.S. Sites for Ongoing Global Phase 1 Clinical Study to Evaluate ATA188 in Patients with Progressive or Relapsing-Remitting Multiple Sclerosis

10/01/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4

10/01/2018 - 13:57

TUCSON, Ariz., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of its latest assay for the [...]

Georgia Health Information Network (GaHIN) Awards $500,000 in Grants

10/01/2018 - 13:33

ATLANTA, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Georgia Health Information Network (GaHIN), the statewide health information exchange (HIE) for Georgia, awarded a total of $500,000 to its members in 2017 to accelerate [...]

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for FT 218 for the Treatment of Narcolepsy

10/01/2018 - 13:30

DUBLIN, Ireland, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ), “Avadel” or “the Company,” today announced that FT 218 has been granted Orphan Drug Designation from the U.S. Food and Drug [...]

FDA Approves Innovative Clinician Programmer for the Medtronic SynchroMed II Intrathecal Drug Delivery System for Chronic Pain and Severe Spasticity

10/01/2018 - 13:01

SynchroMed(TM) II for Chronic Pain Is an Alternative to Systemic Opioids for Many Patients DUBLIN - January 10, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of a new [...]

Evogene Announces Positive 2nd Year Field Trial Results in Corn Bio-Stimulant Ag-Biologicals Program

10/01/2018 - 13:00

REHOVOT, Israel, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a proprietary [...]

Amedisys Honors 18 with Annual Spirit of Excellence Awards

10/01/2018 - 13:00

BATON ROUGE, La., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc., one of the nation’s leading home health, hospice and personal care companies in the nation, recognized 18 employees with the prestigious Spirit of [...]

Announcement no. 01/2018 - Coloplast completes acquisition of SAS Lilial

10/01/2018 - 11:22

Announcement No. 01/2018 10 January 2018 Coloplast completes acquisition of SAS Lilial Coloplast has now completed the acquisition of Lilial. All terms remain as stated in Coloplast’s stock exchange announcement no. 13/ [...]

RadioMedix and AREVA Med announce initiation of Phase 1 clinical trial of AlphaMedix(TM), a Targeted Alpha Therapy for patients with neuroendocrine tumors

10/01/2018 - 11:00

Houston, TX (USA) and Courbevoie (France), Jan. 10, 2018 (GLOBE NEWSWIRE) -- RadioMedix Inc. and AREVA Med today announced the initiation in the United States of Phase 1 trial for AlphaMedix TM in patients with [...]

Medibio Announces ISO 13485 Certification

10/01/2018 - 11:00

SYDNEY, Australia and MINNEAPOLIS, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF) has received a Certificate of Compliance certifying that the Company’s Quality [...]

Basilea announces completion of the license agreement extension with Pfizer for antifungal Cresemba® for China and Asia Pacific

10/01/2018 - 07:16

Basel, Switzerland, January 10, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today the completion of its extension of its license agreement with Pfizer Inc. (NYSE: PFE) for Basilea's antifungal Cresemba ® ( [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

10/01/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 10 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Business Celebrates 160 Years in Louisville

10/01/2018 - 00:31

LOUISVILLE, Ky., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Louisville is known for manufacturing many products, but even before the Louisville Slugger ® bat was created, and bourbon was first bottled, the American Printing [...]

Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering

09/01/2018 - 23:15

HAYWARD, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) today announced that it has completed the second closing of the private placement of its equity securities (“PIPE”) with [...]

Emerald Announces Closing of $15 Million Prospectus Sale

09/01/2018 - 23:14

VICTORIA, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) ("Emerald" or the “Company”) closed today its prospectus sale (the “Offering”) to a single [...]